Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 3A Inducers [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
RELUGOLIX 20,660 958 4.6% 1,699 37 72.4 yrs 1.4%
BOSENTAN 19,581 4,346 22.2% 8,862 303 52.5 yrs 73.2%
PHENYTOIN 14,469 1,449 10.0% 5,241 1,087 46.5 yrs 50.7%
RITONAVIR 11,980 1,190 9.9% 2,925 350 43.8 yrs 43.8%
EFAVIRENZ 7,893 962 12.2% 1,528 252 40.7 yrs 37.7%
NEVIRAPINE 6,651 1,101 16.6% 979 152 35.8 yrs 45.5%
LORLATINIB 5,508 1,542 28.0% 1,232 128 56.5 yrs 54.0%
ELAGOLIX 3,582 5 0.1% 299 37 34.6 yrs 99.7%
BRIGATINIB 3,286 729 22.2% 912 57 61.2 yrs 57.3%
ETRAVIRINE 1,969 257 13.1% 405 74 47.5 yrs 33.5%

Head-to-Head Comparisons

RELUGOLIX vs BOSENTAN RELUGOLIX vs PHENYTOIN RELUGOLIX vs RITONAVIR RELUGOLIX vs EFAVIRENZ BOSENTAN vs PHENYTOIN BOSENTAN vs RITONAVIR BOSENTAN vs EFAVIRENZ PHENYTOIN vs RITONAVIR PHENYTOIN vs EFAVIRENZ RITONAVIR vs EFAVIRENZ
← Back to Cytochrome P450 3A Inducers [MoA] Class side effects →